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Abstract 
Purpose: A complete spinal cord injury (SCI) above the 6th thoracic vertebra (T6) results in 
the loss of sympathetic innervation of the adrenal medulla. This study examined the effect of 
a complete SCI above and below T6 on plasma concentrations of epinephrine, circulating 
interleukin (IL)-6 and other inflammatory cytokines in response to acute strenuous exercise. 
Methods: Twenty-six elite male wheelchair athletes (8=C6-C7 tetraplegic (TETRA); 10=T6-
L1 paraplegic (PARA); 8=non-spinal cord injured controls (NON-SCI)) performed a 
submaximal exercise test followed by a graded exercise to exhaustion on a motorised 
treadmill. Blood samples were taken pre-exercise, post-exercise and 30 min post-exercise 
(post30) and analysed for concentrations of IL-6, IL-10, IL-1 receptor-antagonist (IL-1ra), 
tumor necrosis factor-alpha (TNF-α), epinephrine and cortisol. Results: Circulating IL-6 
concentration was significantly elevated at post-exercise and post30 (~5-fold) in NON-SCI 
and PARA (P=0.003) whereas concentrations in TETRA did not change significantly from 
pre-exercise values. IL-10, IL-1ra and TNF-α were unaffected by exercise in all groups, 
however both SCI groups presented elevated concentrations of IL-10 compared with NON-
SCI (P=0.001). At post-exercise, epinephrine concentrations were significantly higher than 
pre-exercise and post30 concentrations in NON-SCI (~3-fold) and PARA (~2-fold) (P=0.02). 
Plasma epinephrine concentrations were unchanged in TETRA throughout exercise; 
concentrations were significantly lower than NON-SCI and PARA at all-time points. Plasma 
cortisol concentrations were significantly elevated in all groups at post-exercise and post30 
compared with pre-exercise (P<0.001). Total exercise time was similar between groups 
(NON-SCI= 38±6; PARA= 35±5; TETRA= 36±5 min). Conclusion: These findings suggest 
the sympathetic nervous system plays an important regulatory role in the circulating IL-6 
response to exercise and has implications for the metabolic and inflammatory responses to 
exercise in individuals with injuries above T6. 
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Introduction 
Paragraph Number 1 Marked (several-fold) elevations in circulating concentrations of the 
inflammation-responsive cytokine interleukin-6 (IL-6) immediately after strenuous exercise 
are associated with subsequent rises in the plasma concentrations of anti-inflammatory 
cytokines including IL-1 receptor antagonist (IL-1ra), IL-10 and the soluble tumor necrosis 
factor (TNF) receptors (17, 21). It is suggested this transient anti-inflammatory environment 
may be partly responsible for the positive effects of regular exercise in reducing circulating 
concentrations of IL-6 at rest via actions on adipocyte TNF-α and IL-6 release (7). Sustained 
low-level increases in plasma levels of TNF-α and IL-6 have been related to the future 
development of long-term conditions including CVD and type II diabetes (7). 
 
Paragraph Number 2 Contracting skeletal muscle has been confirmed as the primary source 
of elevated concentrations of plasma IL-6 following exercise (23, 24). The rise in cytosolic 
calcium (Ca2+) within contracting myofibres is believed to be a key stimulus for IL-6 release 
(18). In addition, a cross-talk between Ca2+-dependent and stress-induced mitogen-activated 
protein kinase (MAPK)-dependent cell signalling pathways has also been shown to increase 
skeletal muscle IL-6 mRNA expression, particularly in the presence of low muscle glycogen 
(3, 18). In contrast, the role of the sympathetic nervous system (SNS) in the regulation of the 
IL-6 response is less clear. Steensberg et al. (22) reported a 29-fold increase in circulating IL-
6 following a 2.5 h strenuous treadmill run in endurance trained, able-bodied participants. 
However, infusing epinephrine at rest to the same circulating concentrations as observed 
during exercise resulted in only a 6-fold increase in plasma IL-6. Therefore it has been 
suggested that the SNS plays only a minor role in exercise-induced elevations in plasma IL-6 
concentration (5, 22). In contrast both chemical, central and peripheral sympathetic 
denervation using 6-hydroxydopamine inhibited the plasma IL-6 response to exercise in rats 
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(29). To confirm the contribution of the SNS to the exercise-induced IL-6 response in 
humans an in vivo model of attenuated SNS activity is needed. This would allow greater 
understanding of the mechanisms underlying the IL-6 response to acute exercise in humans. 
 
Paragraph Number 3 An injury to the spinal cord results in the loss of central nervous system 
function below the level of the lesion, with the loss of function relative to the level and the 
completeness of the injury (10). The neurons of the sympathetic nervous system are mainly 
located in the thoracic spinal cord (T1 – L1) and a complete injury above the 6th thoracic 
vertebra (T6) results in the loss of sympathetic innervation of the adrenal medulla.  The effect 
of the resulting decreased sympathetic outflow in tetraplegic individuals includes depressed 
circulating epinephrine and norepinephrine plasma concentrations at rest, during and after 
exercise (19, 20).  If it is the case that the SNS plays only a minor role in the IL-6 response to 
exercise, then individuals with complete injuries above T6 would be expected to demonstrate 
elevations in circulating IL-6 concentrations after exercise that are similar to those observed 
in individuals with an intact SNS (i.e. who are injured at or below T6, or who do not have a 
spinal injury).  However, if this is not the case, a limited IL-6 response in those with injuries 
above T6 could have important health implications given the proposed metabolic and 
inflammatory roles of muscle-derived IL-6 in a population with already limited physical 
capacity. 
 
Paragraph Number 4 Previously Kouda et al. (11) have reported an absence of elevations in 
plasma levels of IL-6 and epinephrine immediately after 20 min arm-crank exercise in 
individuals with cervical SCI. Able-bodied controls showed a small, yet significant increase 
in both measures. However, the short duration and moderate exercise workload of 60% OV
2peak may not have been a sufficient stimulus to induce elevations in plasma IL-6 
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concentrations within the SCI group.  To our knowledge, there is no well controlled research 
published that has investigated the effect of spinal cord injury above and below T6 on the 
circulating cytokine response to an acute bout of strenuous exercise. Therefore, the purpose 
of this study was to determine the effect of complete cervical level SCI (i.e. above T6) 
compared with SCI at T6 or below on plasma concentrations of epinephrine, circulating IL-6 
and other inflammatory cytokines in response to ~40 min of graded strenuous exercise. 
Specifically the responses were assessed in highly-trained wheelchair athletes with differing 
levels of spinal injury. A group of wheelchair athletes without a spinal injury were also 
included as a control. We hypothesised that those with SCI above T6 would have an 
attenuated epinephrine and IL-6 response compared with those with an intact SNS.  
 
Methods 
Participants 
Paragraph Number 5 Twenty-six elite male wheelchair athletes (8=C6-C7 tetraplegic 
(TETRA); 10= T6-L1 paraplegic (PARA) and 8= wheelchair athletes without spinal cord 
injury (NON-SCI)) volunteered to participate in the study. All participants were actively 
competing in international level wheelchair basketball or wheelchair rugby. A summary of 
the participants’ characteristics is presented in Table 1. All procedures were approved by the 
Loughborough University ethical advisory committee and performed in accordance with the 
Declaration of Helsinki. All participants provided written informed consent prior to the 
exercise test. All participants were free from infectious symptoms and no incidences of 
pressure sores were reported.  
 
Experimental protocol 
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Paragraph Number 6 Participants reported to the laboratory between 0930 and 1130 having 
been fasted for at least 2 hr. Participants were asked to refrain from strenuous physical 
activity and caffeine intake 24 hr prior to exercise. On arrival participants completed a health, 
training and disability questionnaire and body mass was obtained to the nearest 0.1 kg using 
double-beam seated scales (Marsden MPWS-300, UK). All exercise tests were performed in 
the participants’ competition court sports wheelchair on a motorised treadmill (HP Cosmos, 
Traunstein, Germany). The treadmill exercise protocol is shown in Figure 1. Following a 5 
min warm up at 1.2 m·s¯¹, participants performed ~6 submaximal constant-load 4-min 
exercise stages at ascending speeds at a fixed gradient of 1.0%. The protocol was performed 
according to Goosey-Tolfrey (8) in order to elicit submaximal physiological responses 
covering a range from 40% to 80% peak oxygen uptake ( OV 2peak). This was followed by a 
15-min passive recovery. A graded exercise test to exhaustion (GXT) was then performed at 
a constant speed according to the protocol described by Leicht et al. (12). Briefly, the 
gradient at the start of the GXT was 1.0% for all subgroups, with subsequent increases of 0.3% 
every minute for PARA and NON-SCI and 0.1% every 40 s for TETRA to account for the 
functional differences between groups and ensure a minimum GXT duration of ~8 min (12). 
After the GXT, participants recovered actively at a low intensity (1.2 m·s¯¹) at a 1.0% 
gradient) for 5 min. Participants then performed a verification test, designed as a test to 
exhaustion at the same constant speed but 0.3% and 0.1% higher than the maximal gradient 
achieved during the GXT for NON-SCI/PARA and TETRA respectively (12). The GXT and 
the verification test were terminated when participants were unable to maintain the speed of 
the treadmill. Verbal encouragement was given throughout the test.  
 
Data collection 
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Paragraph Number 7 Expired air was collected during the last minute of each submaximal 
stage and analysed using the Douglas bag technique. The concentration of oxygen and carbon 
dioxide in the expired air samples was determined using a paramagnetic oxygen analyser 
(Series 1400; Servomex Ltd, Sussex, UK) and an infrared carbon dioxide analyser (Series 
1400; Servomex Ltd). Expired air volumes were measured using a dry gas meter (Harvard 
Apparatus, Kent, UK) and corrected to standard temperature and pressure (dry). Oxygen 
uptake ( OV 2), carbon dioxide output, minute ventilation, ventilatory equivalent and 
respiratory exchange ratio were calculated. Expired air was collected for at least the final 3 
consecutive min of the GXT and for 2 min during the verification test. Blood lactate 
concentration (BLa¯) was analysed using a lactate analyser (YSI 1500 SPORT, YSI 
Incorporated, Yellow Springs, Ohio, USA), which was calibrated before each session using a 
lactate standard solution of 5 mmol·L¯¹, provided by the manufacturer. A small capillary 
blood sample was obtained prior to exercise, following each submaximal exercise stage, 
immediately after the GXT and immediately after the verification test. At the same time 
points, participants were asked to indicate an overall rating of perceived exertion (RPE) using 
the 15-point Borg scale according to previous instructions (1). Heart rate was continuously 
recorded at 5-s intervals using short-range radio telemetry (Polar PE 4000, Polar, Kempele, 
Finland). The higher of the two OV 2peak, HRpeak and BLa¯peak values obtained in the GXT and 
the verification test was taken as the peak value. A 4.9 ml blood sample was collected before 
(pre-exercise), immediately after the verification test (post-exercise) and 30 min after 
exercise (post30) from an antecubital vein into a K3EDTA vacutainer. Participants were 
allowed to consume water ad libitum throughout the test. All participants had prior 
experience of the GXT and verification test and were therefore familiar with the protocol.  
 
Blood analyses 
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Paragraph Number 8 Blood samples were refrigerated until the final sample from each 
participant was collected and then spun down together in a refrigerated (4ºC) centrifuge at 
1500g for 10 min.  The separated plasma was then immediately stored at -80ºC. Plasma 
concentrations of IL-6, IL-10, TNF-α, IL-1ra, cortisol and epinephrine were determined using 
quantitative sandwich-type enzyme-linked immunosorbant assay (ELISA) kits (IL-6, IL-10, 
TNF-α, IL-1ra: R&D systems, Abingdon, UK; cortisol: DRG instruments, Marburg, 
Germany; epinephrine: IBL international, Hamburg, Germany), according to the 
manufacturers’ instructions. All samples were analysed in duplicate. The within assay co-
efficient of variation for the analyses performed were as follows: epinephrine: 2.7%; cortisol: 
1.3%; IL-6, 2.9%; IL-10: 2.5%; TNF-α: 3.9%; IL-1ra, 3.7%.  
 
Statistical analysis 
Paragraph Number 9 All data were analysed using the statistical package IBM SPSS for 
windows version 19 (SPSS inc, Chicago, IL).  Using the data from Kouda et al. (11) and 
Umemoto et al (25) as a foundation for our calculations we based our sample size calculation 
on a 2-fold increase in circulating IL-6 with a pooled SD of 80%.  Using GPower 3.1.5, we 
calculated we would need 8 participants in each group to detect a similar change in plasma 
IL-6 concentration, with an effect size of 1.25, 90% power and an α of 5%. 
 
Paragraph Number 10 Normal distribution of the outcome variables was confirmed for IL-
1ra, TNF-α and cortisol. Data were analysed in a two factor (group x time of measurement) 
mixed measures ANOVA. Results for IL-6, IL-10, and epinephrine violated the assumptions 
of normal distribution and therefore the same statistical analysis was performed on the log-
transformed data. Subsequently where significant F-ratios were shown, separate one-way 
repeated measures ANOVA with Tukey post-hoc tests were employed to determine changes 
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across time within each group. Separate one-way between measures ANOVA with Tukey 
post-hoc tests were employed to determine differences between groups at each time point. A 
Bonferroni adjustment was performed on the unadjusted alpha value when performing 
multiple comparisons. For comparisons where the assumption of sphericity was violated, a 
Greenhouse-Geisser correction was applied. Data are presented as mean ± standard deviation 
(SD). Non- parametric RPE data are presented as median and (quartiles). Significance was set 
a priori at P≤0.05. Effect sizes (partial eta2 (ES)) are presented whereby 0.2 refers to a small 
effect, 0.5 a moderate effect and 0.8 a large effect according to Cohen (4).  
 
Results 
Paragraph Number 11 The peak physiological and perceived exertional responses for each 
group are provided in Table 2. Total exercise time was no different between groups 
(TETRA= 36±5; PARA= 35±5; NON-SCI= 38±6 min). The range of mean relative exercise 
intensities for TETRA, PARA and NON-SCI during the incremental submaximal exercise 
stages were 41%-83%, 33%-78%; 32%-81% OV 2peak respectively.  
 
Paragraph Number 12 A ~ 5-fold elevation in circulating IL-6 concentration was seen in in 
PARA and NON-SCI at post30 (Fig 2a). Compared with pre-exercise values, plasma IL-6 
concentrations were significantly elevated at post-exercise and post30 (P=0.003 for 
interaction; ES = 0.59) in PARA and NON-SCI only. In TETRA, plasma IL-6 concentrations 
did not change significantly from those at pre-exercise. Plasma IL-10 concentrations were 
unaffected by exercise in all groups (Fig. 2b).  However, plasma IL-10 concentrations were 
higher in TETRA and PARA than in NON-SCI (P=0.001for group; ES = 0.45). There were 
no significant interaction effects or main effects of group and time for plasma concentration 
of IL-1ra and TNF-α (Figs 2c and 2d).  
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Paragraph Number 13 At post-exercise, plasma epinephrine concentrations increased 
significantly above pre-exercise values in PARA and NON-SCI only (P<0.002 for interaction; 
ES = 0.45) (Fig 3a). Plasma epinephrine levels in PARA and NON-SCI were markedly 
higher than those in TETRA (P<0.001 for group, ES = 0.83), where values remained close to 
pre-exercise values throughout. Plasma cortisol concentration increased after exercise in all 
groups, with values at post-exercise and post30 (all P<0.001 for time; ES = 0.60) 
significantly higher than at pre-exercise (Fig. 3b). There were no differences between groups 
at any time point.  
 
Discussion 
Paragraph Number 14 The present study examined the effect of spinal cord injury level on 
the circulating cytokine responses to an acute bout of strenuous wheelchair propulsive 
exercise in highly trained wheelchair athletes. The main finding was that those with a 
disrupted SNS (TETRA) demonstrated an attenuated IL-6 response to exercise compared 
with the ~ 5-fold elevation in circulating IL-6 concentrations observed at post30 in those with 
an intact SNS (SCI at or below T6; PARA and NON-SCI).  In accordance with previous 
literature (19, 20), both PARA and NON-SCI exhibited significant increases in plasma 
epinephrine concentration at post-exercise, whereas values remained close to pre-exercise in 
TETRA. This would suggest that, in contrast to previous suggestions, the SNS contributes to 
the exercise-induced, skeletal muscle IL-6 response. The attenuated epinephrine, and 
therefore (peripheral) SNS response is in contrast to the significant activation of the 
hypothalamic-pituitary-adrenal (HPA) axis as evidenced by marked elevations in plasma 
cortisol concentration after exercise observed in each group. Our findings therefore support 
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the view that the HPA axis plays only a minor role in exercise-induced elevations in plasma 
IL-6 (7).  
 
Paragraph Number 15 The magnitude of the IL-6 response is dependent on exercise intensity 
and duration where intensity directly reflects the contractile activity within the active muscle 
mass (18). The increases in plasma concentrations of IL-6 observed here in PARA and NON-
SCI are greater than those seen in previous work investigating the myokine response to 20 
min arm-crank ergometry (11) and similar to those seen following 2 h of arm-crank 
ergometry (25). The overall magnitude of IL-6 response in the present study may have been 
attenuated due to the rest period employed prior to the GXT; however this was the same for 
all groups and would not affect the between groups analysis. Comparisons between cervical 
SCI and thoracic SCI or NON-SCI groups should acknowledge the differences in absolute 
workload evident when performing exercise at the same relative intensity. In this study, all 
participants performed exercise to exhaustion. Although absolute intensity would be lower in 
TETRA as a result of a lower functional capacity, this group still performed ~35 min of 
exercise with post-exercise RPE of 20 and post-exercise blood lactate, VE/ OV 2 and RER 
values reflecting the demanding nature of the protocol. The HRpeak of ~130 b·min¯¹ 
(compared to values of ~180 in PARA and NON-SCI) is considered ‘maximal’ in this group 
and is a result of the attenuated sympathetic drive in this population, with increases in HR 
during exercise the result of withdrawal of parasympathetic tone (26).  
 
Paragraph Number 16 In the present study, despite performing exercise of the same relative 
intensity and duration, available muscle mass was lower in TETRA than PARA and NON-
SCI as a consequence of their higher spinal cord lesion level. This difference in active muscle 
mass could therefore be argued to account for the attenuated IL-6 response. However, data 
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from published literature suggests that even small muscle mass is capable of releasing IL-6. 
Using a model of whole body exercise Helge et al. (9) recently reported that IL-6 release 
relative to lean limb mass is greater from the upper limb compared with lower limb despite a 
lower oxygen demand and glycogen utilization during upper limb exercise. Furthermore, it 
has previously been proposed that when performing the same absolute intensity the stimulus 
for IL-6 release is stronger for a small muscle mass than a larger muscle mass as the force 
production per unit of muscle is higher (23). This, together with the data of Helge et al. (9) 
and the maximal nature of the exercise protocol, support that the attenuated IL-6 response 
observed here in TETRA cannot be attributed merely to differences in absolute workload.  
 
Paragraph Number 17 The current study describes the circulating IL-6 response to exercise, 
although it has been shown that post-exercise increases in plasma IL-6 can be almost solely 
attributed to muscle IL-6 release (23, 24). To date any role of the SNS on exercise-induced 
cervical level SCI and therefore a disrupted SNS is potentially limited by the low intensity 
and short duration of the exercise performed (11). Infusion of physiological concentrations of 
epinephrine in vivo has been shown to induce a 6-fold increase in plasma concentrations of 
IL-6 in resting humans (i.e. independent of muscular contraction). However, exercise that 
elicited the same physiological concentrations of epinephrine resulted in a 29-fold increase in 
IL-6 (22), leading to the suggestion that any role of the SNS in the IL-6 release from muscle 
during exercise is only trivial. In contrast, sympathectomised animals show complete 
attenuation of the plasma IL-6 response to exercise (29) and our comparable response in 
individuals with high level SCI supports the involvement of the SNS in the release of IL-6 
from contracting skeletal muscle.  
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Paragraph Number 18 Nevertheless, the exact mechanism whereby the SNS regulates the 
synthesis of IL-6 within, or release of IL-6 from, contracting skeletal muscle can only be 
proposed; potential roles for the SNS include the activation of myofibre IL-6 protein 
synthesis and/or the activation of the transporter mechanisms responsible for IL-6 release. 
For example, Frost et al. (6) reported a 40-fold increase in IL-6 mRNA expression and a 15-
fold increase in skeletal muscle IL-6 protein content following the resting infusion of 
epinephrine in rats which was blunted by infusion of α-adrenergic and a β1/2 -adrenergic 
antagonists. Furthermore epinephrine infusion has been shown to initiate a two-fold increase 
in the activity of Jun N-terminal kinase (JNK), a regulator of IL-6 mRNA expression, with 
this effect inhibited by the inclusion of α- and β-adrenergic receptor blockades (16). 
Elsewhere contraction-mediated JNK signalling has been speculated as a primary mechanism 
for the increased IL-6 expression in contracting muscle over Ca2+ and other MAPK dependant 
signalling pathways (27). Therefore a synergy between contraction induced and SNS 
activated signalling pathways for muscle IL-6 expression following exercise may be 
considered. It may also be proposed that β-adrenoreceptor stimulated vasodilation may 
increase the perfusion of contracting skeletal muscle, thereby facilitating IL-6 release and the 
subsequent elevation in circulating concentrations in those with intact SNS activation.  
  
Paragraph Number 19 In contrast to previous literature this study did not observe any post-
exercise elevations in the circulating concentrations of the anti-inflammatory cytokines IL-10 
or IL-1ra (17, 21). These elevations usually follow the peak in IL-6 (5). With this in mind, 
our findings may simply reflect the short duration of the post-exercise sampling period 
employed in the study protocol. Plasma IL-6 concentrations in PARA and NON-SCI were 
highest at the final blood sample (30 min post-exercise). Therefore, a lag in any IL-6-induced 
anti-inflammatory cytokine release is likely. Additional samples 1 to 2 h after exercise would 
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have been beneficial to identifying any anti-inflammatory cytokine response later in the post-
exercise period.  
 
Paragraph Number 20 Previous studies have shown higher resting levels of IL-6 at rest in 
sedentary individuals with spinal injuries compared with those without SCI and this has been 
related to risk of future development of chronic long-term inflammatory conditions (11, 25).  
In contrast, in the present study, resting plasma concentrations of IL-6 and the pro-
inflammatory cytokine TNF-α did not differ between the groups at rest.  This may reflect the 
highly-trained nature of the participants in this study.  However, one unexpected finding from 
this study is the higher circulating concentrations of IL-10 in TETRA and PARA compared 
with NON-SCI. The principal function of IL-10 appears to be to limit and ultimately 
terminate inflammatory responses and its principle source appears to be regulatory T cells 
(15).  With this in mind, these data may suggest a strong anti-inflammatory adaptation in 
these athletes. On the other hand, IL-10 also has inhibitory effects on toll-like receptor 
expression and macrophage antigen presentation (13, 14) among other inhibitory immune cell 
actions and thus has the potential to suppress immunity if produced in excess. SCI is 
associated with depressed immune cell functions (2, 28) and therefore the elevated resting 
levels of IL-10 may be related to the increased frequency of infections experienced by those 
with SCI.   
 
Paragraph Number 21 In conclusion, the findings from this study suggest the SNS plays an 
important regulatory role in the circulating IL-6 response to exercise. Our findings support a 
role for the SNS as an important modulator of the release and/or synthesis of IL-6 from 
contracting skeletal muscle. This has important health implications for individuals with 
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cervical level spinal injuries as exercise-induced elevations in plasma IL-6 have previously 
been related to the creation of an anti-inflammatory environment in the hours post-exercise.  
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Figure 1 Exercise protocol. Measurement of: O2 = oxygen uptake; L = blood lactate; x = 
overall RPE. 
 
Figure 2 Plasma cytokine responses to an acute bout of graded strenuous exercise. Time 
effects: ^ = NON-SCI and PARA significantly different from pre-exercise (P<0.05). Group 
effects: *= NON-SCI and PARA significantly different from TETRA (P<0.05). †= TETRA 
and PARA significantly different from NON-SCI (P<0.05). Data are mean ± SD.  
 
Figure 3 Plasma epinephrine and cortisol responses to an acute bout of graded 
strenuous exercise. Time effects: ^ = All groups significantly different from pre-exercise 
(P<0.05). †= NON-SCI and PARA significantly different from pre and post30 exercise 
(P<0.05). Group effects: *= NON-SCI and PARA significantly different from TETRA 
(P<0.05). Data are mean ± SD.  
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Table 1 Participants’ characteristics  
 TETRA PARA NON-SCI 
Age (yr) 31±6 30 ±8 27±8 
Body Mass (kg) 67.3±5.9 † 72.3±13.5 84.8±10.7 
Lesion level/ Disability C6/ 7 T6–L1, Spina Bifida Amputee, Club foot 
ASIA impairment scale A A - 
TSI (yr) 11±6 19±7 11±5 
WC sport Rugby (n=8) Basketball (n=10) Basketball (n=8) 
Training (h·wk¯¹) 13±2 15±3 16±2 
Time in sport (yr) 11±3 14±6 10±6 
 
TETRA = cervical SCI; PARA = thoracic SCI below T6; NON-SCI = non-spinal injured; 
ASIA = American spinal injury association; TSI = time since injury; WC = wheelchair 
 
† Significant difference, TETRA vs. NON-SCI, P<0.05 
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Table 2 Physiological and exertional responses  
 TETRA PARA NON-SCI 
OV 2peak (L·min¯¹)   1.44±0.32 † 2.85±0.87 ‡ 3.75±0.33 
HRpeak (b·min¯¹) 127±10 † 181±10 183±8 
BLa p¯eak (mmol·L¯¹) 5.39±0.96 † 7.69±1.87 8.29±1.64 
Overall RPEpeak 20 (19,20) 19 (19,20) 20 (19,20) 
VE/ OV 2 37.7±4.9 36.2±3.7 34.1±3.5 
RER 1.11±0.08 1.15±0.06 1.18±0.06 
GXT time (min) 8.7±0.8 8.8±0.9 9.5±0.7 
VER time (min) 2.0±0.0 1.9±0.4 1.9±0.3 
 
TETRA = cervical SCI; PARA = thoracic SCI below T6; NON-SCI = non-spinal injured; OV
2peak = peak oxygen uptake; HRpeak = peak heart rate; BLa¯peak = peak blood lactate 
concentration; RPEpeak = peak rating of overall perceived exertion; VE = pulmonary 
ventilation OV 2 =oxygen uptake; VE/ OV 2 = ventilatory equivalent for oxygen; RER = 
respiratory exchange ratio; GXT = graded exercise test; VER = verification test 
 
†significant difference, TETRA vs. PARA and NON-SCI, P<0.05 
‡significant difference, PARA vs. NON-SCI, P<0.05 
 
 
 
